Q2 FY27 profit up 6%; biological launches planned for FY29 and FY31
CHAMBLFERT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Smallcap 250 and 0.1 pts less than its Fertilizers peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q2 FY27 operating income rose 9% year on year to INR 69,995 million. Operating profit before depreciation, interest and tax rose 7%, while the company's net profit rose 6% to INR 6,350 million. H1 income fell 1%, but operating profit rose 9% and profit rose 8%. Solid TAN production began in August 2026. Management targets five biological launches in FY2028-29 and five more in FY2030-31. A urea plant is being prepared, pending approvals.
Profit growth and new TAN and biological launches support future growth, but lower H1 revenue, higher finance costs and JV losses remain risks.